Sign in

CIK 0001999480 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Alto Neuroscience, Inc.

Sign in to watch
Ticker
ANRO
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
834210124
Phone
773-255-5012
Business address
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. 4 Option exercise PRESIDENT AND CFO acquired 55,000 shares (option exercise)
  5. 4 Open-market sale PRESIDENT AND CFO sold 134,886 shares at an average $26.45 ($3,567,247)
  6. 144 Insider Sale of Securities
  7. 8-K Event Executive or director change
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. 8-K Event Material agreement
  16. 424B5 Offering Prospectus
  17. 8-K Event Results of operations · Other events
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 8-K Event Executive or director change

Page 1 of 10 · 198 filings